For professional investors only. When you trade ETFs, your capital is at risk.
As the world resets growth expectations, the secular growth story of cannabis remains largely untold in the background. Over the past couple years, investors have been working diligently through a price-discovery phase for the sector which is newly legalised and regulated.
During this webinar, we provide an outlook for the sector, explore recent industry news, macro developments and highlight the 'silver linings' for the medical cannabis sector in light of the stock market carnage caused by COVID-19. We also give a performance and constituent review of Europe's first cannabis UCITS ETF - The Medical Cannabis and Wellness ETF (CBDX).
During this webinar we will cover:
· Macro overview: A Q1 for the books
· Sector performance: Winners and losers
· Cannabis news: Opportunity in a sea of red
· Forward looking: Catalysts on the horizon